Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Samrat Pharmachem Limited - has informed BSE Ltd that the meeting of Board of Directors of the Company is scheduled on 14/11/2026, to consider and approve the Un-audited financial results for the quarter ended September 30, 2026.

September 26, 2026 Department of Corporate Services, BSE Limited 25th Floor, P J Towers, Dalal Street, Mumbai - 400 001. Ref: Scrip Code: 530125 Sub: Notice of Board Meeting for Un-Audited Financial Results for the quarter ended September 30, 2026 Dear Sir / Madam, We are enclosing herewith a copy of notice convening Board Meeting on Saturday, the 14th day of November, 2026 for considering and taking on record the Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the quarter ended September 30, 2026. Further as per Regulation 46 of SEBI (Listing Obligations and Disclosure Requirements) regulations, 2015 (LODR), notice of the Board meeting would be made available on the website of the Company at www.samratpharmachem.com Please take the above intimation on records. Thanking you, Yours faithfully, For Samrat Pharmachem Limited Nishant Kankaria Company Secretary & Compliance Officer = = = = = = = = N O T I C E = = = = = = = = Pursuant to Regulation 29(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held at 02:00 P.M. on Saturday, the 14th day of November, 2026 at the Corporate Office of the Company at 701/702, Business Square, M. A. Road, Andheri (West), Mumbai – 400058, inter alia, to consider and take on record the Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the quarter ended September 30, 2026. The Company shall intimate to the exchanges the Un-Audited Financial Results upon the conclusion of the aforesaid Board Meeting and will arrange for the announcement of the same in the Press and on the company’s website as required under the Listing Agreement. By Order of the Board of Directors For Samrat Pharmachem Limited Date : September 26, 2026 Place : Mumbai Nishant Kankaria Company Secretary & Compliance Officer